The TOP Factor: a new journal metric to assess transparency and reproducibility policies
Find out more about the TOP Factor, an alternative metric to the impact factor, evaluating academic journals based on open science policies.
COVID-19: ISMPP issues guidance regarding authorship challenges
Find out more about ISMPP’s guidance for navigating author non-responsiveness in the wake of the coronavirus pandemic.
Improving transparency in the reporting of systematic reviews without meta-analysis
Find out why guidance is needed and what’s covered in the new Synthesis Without Meta-analysis (SWiM) guidelines.
Is preregistering scientific research becoming mainstream?
PLOS ONE now offers Registered Reports, shifting peer review focus from results to the quality of study design. Is this part of the future of open science?
The ICMJE announces a new author disclosure form: what has changed and why?
Find out more about the impact the new ICMJE disclosure form will have on authors publishing in medical journals.
Successes and challenges in data sharing: insights from the YODA Project
With widespread and growing support for increased data sharing, what can we learn from the Yale Open Data Access (YODA) Project and its collaboration with Johnson & Johnson?
Should researchers be able to suggest peer reviewers?
Many journals ask submitting authors to suggest recommended peer reviewers, potentially risking bias and misconduct. Do the benefits outweigh these risks?
New updates to the ICMJE’s reporting recommendations: focus on transparency
We summarise the key changes to the ICMJE recommendations for authors and medical publication professionals.
Can you trust an article’s abstract?
Abstract ‘spin’ can distort a study’s findings and lead to inappropriate conclusions being drawn. But just how prevalent is this problem?
[VIDEO] Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
Gemma Rogers, Communications Director at Oxford Pharmagenesis, discusses a study on clinical trial transparency.
[VIDEO] Professional medical writing support and the quality, ethics and timeliness of clinical trial reporting: a systematic review
Obaro Evuarherhe, Principal Consultant at Oxford PharmaGenesis, discusses professional medical writing support and the quality, ethics and timeliness of clinical trial reporting.
MPIP: Overcoming barriers to open access for industry
A new tool from MPIP provides easily accessible information on open access options for industry-funded research.
Does professional medical writing support impact the quality, ethics and timeliness of clinical trial reporting?
Findings of a systematic review show working with professional medical writers positively affects measures of quality, ethics and timeliness.
Are European universities failing to report clinical trial data in a timely manner?
A recent article from Nature news delves into clinical trial reporting following evidence showing that some universities are failing to meet EU regulations.
CBI’s 8th Annual Publication and Clinical Trial Transparency Europe
Join CBI for the latest updates on data sharing, collaborating with patients and innovations in publishing.
Five essential factors for data sharing
Discover the five areas for improvement identified in Springer Nature’s recent surveys of researchers, aiming to promote data sharing.